Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 130

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 130
---
 will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement, or if you currently receive multiple proxy statements and would prefer to participate in householding, please notify your broker if your shares are held in a brokerage account or us if you hold registered shares. You can notify us by sending a written request to 100 SE 2nd Street Suite 2000 #1009, Miami, FL, 33131, Attention: Corporate Secretary.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We file annual, quarterly and current reports, proxy statements and other information with the SEC. Such filings are made available on our Internet website, www.telomirpharma.com, as soon as reasonably practicable after they are filed with, or furnished to, the SEC. The information on our website is not, and shall not be deemed to be, a part of this Proxy Statement or incorporated into any other filings we make with the SEC. The SEC maintains an Internet site, www.sec.gov, which contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including the Company.

<div align='center'>INFORMATION INCORPORATED BY REFERENCE</div>

This proxy statement incorporates by reference the documents listed below that TELO has previously filed with the SEC (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules). They contain important information about TELO and its financial condition.

| ● 
 ● | Annual                                                                                                                             
 Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 4, 2025.                           
 Quarterly                                                                                                                          
 Report on Form 10-Q for the for the quarterly period ended September 30, 2025 filed with the SEC on November 10, 2025;             |
|:--|:-----------------------------------------------------------------------------------------------------------------------------------|
| ● | Current                                                                                                                            
 Reports on Form 8-K filed with the SEC on January 7, 2025, January                                                                 
 28, 2025, February                                                                                                                 
 18, 2025, February                                                                                                                 
 20, 2025, February                                                                                                                 
 25, 2025, March                                                                                                                    
 19, 2025, May                                                                                                                      
 7, 2025, May